Compare DRTS & GIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRTS | GIII |
|---|---|---|
| Founded | 2015 | 1956 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2021 | 2006 |
| Metric | DRTS | GIII |
|---|---|---|
| Price | $13.40 | $31.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | $20.60 | ★ $34.75 |
| AVG Volume (30 Days) | ★ 502.7K | 386.5K |
| Earning Date | 11-27-2026 | 12-08-2026 |
| Dividend Yield | N/A | ★ 1.27% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.95 |
| Revenue | N/A | ★ $2,957,012,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,793.58 | $1.17 |
| P/E Ratio | ★ N/A | $16.18 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.43 | $24.61 |
| 52 Week High | $15.79 | $37.54 |
| Indicator | DRTS | GIII |
|---|---|---|
| Relative Strength Index (RSI) | 47.69 | 60.28 |
| Support Level | $12.33 | $26.69 |
| Resistance Level | $13.95 | $32.58 |
| Average True Range (ATR) | 0.64 | 0.91 |
| MACD | 0.06 | 0.06 |
| Stochastic Oscillator | 38.02 | 58.72 |
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
G-III Apparel Group Ltd is an apparel manufacturing company. The company makes a wide range of apparel, footwear, and accessories that sells under its own brands, licensed brands, and private-label brands. It has a substantial portfolio for licensed and proprietary brands, anchored by brands: DKNY, Donna Karan, Karl Lagerfeld, Karl Lagerfeld Paris, Vilebrequin, and others. The reportable segments of the company are Wholesale Operations and Retail Operations. The Wholesale operations segment includes sales of products under brands licensed by from third parties, and sales of products under its own brands and private label brands. The retail operations segment consists of Wilsons Leather, G.H. Bass, and DKNY retail stores. It derives majority of its revenue from Wholesale operations.